Stryker Corporation $SYK Shares Purchased by Lyell Wealth Management LP

Lyell Wealth Management LP boosted its holdings in Stryker Corporation (NYSE:SYKFree Report) by 2.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 38,010 shares of the medical technology company’s stock after acquiring an additional 869 shares during the period. Stryker accounts for about 1.2% of Lyell Wealth Management LP’s portfolio, making the stock its 28th largest holding. Lyell Wealth Management LP’s holdings in Stryker were worth $15,038,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Mar Vista Investment Partners LLC raised its position in Stryker by 10.2% in the first quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company’s stock valued at $33,572,000 after purchasing an additional 8,353 shares during the period. United Services Automobile Association purchased a new stake in Stryker in the first quarter valued at approximately $2,857,000. AXS Investments LLC raised its position in Stryker by 13.7% in the first quarter. AXS Investments LLC now owns 8,827 shares of the medical technology company’s stock valued at $3,286,000 after purchasing an additional 1,062 shares during the period. Park Edge Advisors LLC purchased a new stake in Stryker in the second quarter valued at approximately $679,000. Finally, Hendley & Co. Inc. raised its position in Stryker by 60.3% in the second quarter. Hendley & Co. Inc. now owns 14,018 shares of the medical technology company’s stock valued at $5,546,000 after purchasing an additional 5,274 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Stryker

In other news, insider Viju Menon sold 500 shares of the stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the completion of the sale, the insider owned 12,511 shares in the company, valued at approximately $4,886,921.71. This represents a 3.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the sale, the director owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on SYK. BTIG Research upped their price objective on Stryker from $407.00 to $408.00 and gave the stock a “buy” rating in a research report on Monday, October 13th. Rothschild Redb raised Stryker to a “hold” rating in a research report on Thursday, September 18th. Needham & Company LLC upped their price objective on Stryker from $442.00 to $448.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Evercore ISI cut their price objective on Stryker from $418.00 to $410.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 7th. Finally, Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research report on Saturday. Fifteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $431.76.

Check Out Our Latest Analysis on Stryker

Stryker Stock Performance

NYSE SYK opened at $374.67 on Monday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. The company has a market capitalization of $143.24 billion, a PE ratio of 49.63, a P/E/G ratio of 2.70 and a beta of 0.94. The company has a fifty day moving average of $379.40 and a two-hundred day moving average of $378.85.

Stryker (NYSE:SYKGet Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.07 by $0.06. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. During the same quarter in the prior year, the firm posted $2.81 earnings per share. Stryker’s revenue for the quarter was up 11.1% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s dividend payout ratio is currently 44.50%.

Stryker Company Profile

(Free Report)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

See Also

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYKFree Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.